Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Hormone Therapy in Treating Patients With Prostate Cancer

ClinicalTrials.gov ID: NCT00003323

Public ClinicalTrials.gov record NCT00003323. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of Potency-Sparing Hormonal Therapy in Patients With Elevated Serum PSA After Radiation Therapy or Radical Prostatectomy for Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Male hormones can stimulate the growth of prostate cancer cells. Hormone therapy using flutamide and finasteride may fight prostate cancer by reducing the production of male hormones. PURPOSE: Phase II trial to study the effectiveness of flutamide and finasteride in treating prostate cancer patients with high PSA levels who were previously treated with radiation therapy or radical prostatectomy.

Study identification

NCT ID
NCT00003323
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
101 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 1998 (Type not available)
Primary completion
May 2002 (Actual)
Completion
Mar 2010 (Actual)
Last update posted
Jul 4, 2016

1998 – 2010

United States locations

U.S. sites
43
U.S. states
21
U.S. cities
29
Facility City State ZIP Site status
Veterans Affairs Medical Center - Birmingham Birmingham Alabama 35233-1996 —
University of California San Diego Cancer Center La Jolla California 92093-0658 —
Veterans Affairs Medical Center - San Francisco San Francisco California 94121 —
UCSF Cancer Center and Cancer Research Institute San Francisco California 94143-0128 —
CCOP - Christiana Care Health Services Wilmington Delaware 19899 —
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307-5000 —
CCOP - Mount Sinai Medical Center Miami Beach Florida 33140 —
Veterans Affairs Medical Center - Chicago (Westside Hospital) Chicago Illinois 60612 —
University of Chicago Cancer Research Center Chicago Illinois 60637-1470 —
Holden Comprehensive Cancer Center at The University of Iowa Iowa City Iowa 52242-1009 —
Veterans Affairs Medical Center - Togus Togus Maine 04330 —
Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore Maryland 21201 —
Dana-Farber Cancer Institute Boston Massachusetts 02115 —
University of Massachusetts Memorial Medical Center Worcester Massachusetts 01655 —
Veterans Affairs Medical Center - Minneapolis Minneapolis Minnesota 55417 —
Veterans Affairs Medical Center - Columbia (Truman Memorial) Columbia Missouri 65201 —
Ellis Fischel Cancer Center - Columbia Columbia Missouri 65203 —
Barnes-Jewish Hospital St Louis Missouri 63110 —
Washington University Siteman Cancer Center St Louis Missouri 63110 —
University of Nebraska Medical Center Omaha Nebraska 68198-3330 —
CCOP - Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
Norris Cotton Cancer Center Lebanon New Hampshire 03756-0002 —
Veterans Affairs Medical Center - Buffalo Buffalo New York 14215 —
Roswell Park Cancer Institute Buffalo New York 14263-0001 —
CCOP - North Shore University Hospital Manhasset New York 11030 —
Schneider Children's Hospital at North Shore Manhasset New York 11030 —
Memorial Sloan-Kettering Cancer Center New York New York 10021 —
New York Presbyterian Hospital - Cornell Campus New York New York 10021 —
Mount Sinai Medical Center, NY New York New York 10029 —
State University of New York - Upstate Medical University Syracuse New York 13210 —
Veterans Affairs Medical Center - Syracuse Syracuse New York 13210 —
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. Syracuse New York 13217 —
Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina 27599-7295 —
Veterans Affairs Medical Center - Durham Durham North Carolina 27705 —
Duke Comprehensive Cancer Center Durham North Carolina 27710 —
CCOP - Southeast Cancer Control Consortium Winston-Salem North Carolina 27104-4241 —
Comprehensive Cancer Center at Wake Forest University Winston-Salem North Carolina 27157-1082 —
Rhode Island Hospital Providence Rhode Island 02903 —
University of Tennessee, Memphis Cancer Center Memphis Tennessee 38103 —
Veterans Affairs Medical Center - Memphis Memphis Tennessee 38104 —
Veterans Affairs Medical Center - White River Junction White River Junction Vermont 05009 —
Veterans Affairs Medical Center - Richmond Richmond Virginia 23249 —
MBCCOP - Massey Cancer Center Richmond Virginia 23298-0037 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003323, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 4, 2016 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00003323 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →